| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/01/2001 | US6225064 Ligating oligonucleotides to 3' termini of sample dna fragment groups, mixing ligated products together, amplifying using polymerase chain reaction and primers complementary to oligonucleotides, and detecting; comparison of plural samples |
| 05/01/2001 | US6225059 Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics |
| 05/01/2001 | US6225057 Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection |
| 05/01/2001 | US6225055 Apparatus for the parallel alignment of macromolecules, and use thereof |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225051 An emission layer comprising atleast one receiving compound and an emitting compound which is di, tri or tetravalent metal phthalocyanine or porphine compound |
| 05/01/2001 | US6225047 Use of retentate chromatography to generate difference maps |
| 05/01/2001 | US6225046 Method for detecting microorganisms |
| 05/01/2001 | US6225043 Immunoassay in which one of the species is masked and not capable of undergoing specific binding unless reacted with enzyme which exposes antigenic ligand |
| 05/01/2001 | US6224902 Mixture of delivery vehicle and sterol |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224865 Suppression of inhibitors |
| 05/01/2001 | US6224862 Mixture of prothrombinase and protein; anticoagulant |
| 05/01/2001 | US6224831 Microassay device and methods |
| 05/01/2001 | US6224727 NOx sensor |
| 05/01/2001 | US6224644 Cyanine dyes and synthesis methods thereof |
| 05/01/2001 | US6224550 Method for monitoring the level of an osmotically active component in body fluid and device for carrying out said method |
| 05/01/2001 | US6223604 Mobile truss testing apparatus |
| 05/01/2001 | US6223589 Oil quality sensor |
| 05/01/2001 | US6223588 Dew point and bubble point measurement |
| 05/01/2001 | CA2121473C Methods and compositions for treating allergic reactions |
| 05/01/2001 | CA2075042C Manipulation of solid, semi-solid or liquid materials |
| 05/01/2001 | CA2067333C Production of genetically-engineered vaccines for aids and retroviral diseases |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341222C Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 04/29/2001 | CA2322903A1 Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma |
| 04/29/2001 | CA2286401A1 Methods of diagnosing and treating melanoma utilizing tyrp2 |
| 04/28/2001 | CA2288419A1 Electronic device for sensing gases and emitting a voice safety message |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029563A1 Method of screening for inhibitors of asp2 |
| 04/26/2001 | WO2001029562A1 A method for the assessment of allergenicity |
| 04/26/2001 | WO2001029560A1 Electrochemical enzyme immuno assay |
| 04/26/2001 | WO2001029559A1 Systems and methods for performing magnetic chromatography assays |
| 04/26/2001 | WO2001029558A1 A test strip provided device with a lid-provided pretreatment portion |
| 04/26/2001 | WO2001029557A2 Method and apparatus for determination of properties of food or feed |
| 04/26/2001 | WO2001029556A1 Humidity detector calibration method |
| 04/26/2001 | WO2001029555A2 Monofluorinated polycyclic aromatic compounds and the use thereof as additive polycyclic aromatic compounds |
| 04/26/2001 | WO2001029541A1 Device for measuring water quality |
| 04/26/2001 | WO2001029268A2 Method for identifying interacting gene products |
| 04/26/2001 | WO2001029264A2 Nucleic acid primers and probes for detecting tumor cells |
| 04/26/2001 | WO2001029257A2 Methods of genetic cluster analysis |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029250A1 Quantification of paralyzing toxins (psp) by fluorimetry in excitable cells |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029218A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | WO2001029214A1 Colon-tumour-associated antigens |
| 04/26/2001 | WO2001029207A1 Antiuracil monoclonal antibody |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029198A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | WO2001029197A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029090A1 Immunological assay for detection of antibodies in celiac disease |
| 04/26/2001 | WO2001029081A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | WO2001029079A1 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
| 04/26/2001 | WO2001029072A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029069A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | WO2001029068A2 A eag gene encoding for a potassium channel |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029054A2 Medicaments for treatment of respiratory syncytial virus infections |
| 04/26/2001 | WO2001029036A2 Allosteric sites on muscarinic receptors |
| 04/26/2001 | WO2001028700A1 Transiently dynamic flow cytometer analysis system |
| 04/26/2001 | WO2001028652A1 Blood processing systems which monitor optical densities |
| 04/26/2001 | WO2001028621A1 Automated collection systems and methods for obtaining red blood cells, platelets, and plasma from whole blood |
| 04/26/2001 | WO2001028594A2 Tumor detection by imaging and therapy of tumors |
| 04/26/2001 | WO2001028587A2 Magnetic targeted carrier |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028579A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | WO2001028540A2 Agent for treating cephalic pain |
| 04/26/2001 | WO2001028533A2 PRODUCTS AND METHODS FOR ACTIVATING PPARη-RXR AND UP-REGULATING MONOCYTE/MACROPHAGE CD36 FOR THE TREATMENT OF MALARIA |
| 04/26/2001 | WO2001028532A2 Methods and compositions for predicting, diagnosing and treating lipodystrophy |
| 04/26/2001 | WO2001028512A1 Selective removal of contaminants from a surface using articles having magnets |
| 04/26/2001 | WO2001028500A2 Uses of antileukoprotease in carcinoma |
| 04/26/2001 | WO2001028428A1 Sample taking device |
| 04/26/2001 | WO2001028416A1 Physiological monitor and associated computation, display and communication unit |
| 04/26/2001 | WO2001028415A1 Animal health diagnosis |
| 04/26/2001 | WO2001028324A1 Methods for identifying a preferred liver transplant donor |
| 04/26/2001 | WO2001028321A1 Diabetes onset model mammal |
| 04/26/2001 | WO2001006990A3 Use of etodolac to treat cancer |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2001001151A3 Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan antibodies |
| 04/26/2001 | WO2000077040A3 Human intracellular signaling molecules |
| 04/26/2001 | WO2000072007A3 Method for diagnosing tse-induced changes in tissues using infrared spectroscopy |
| 04/26/2001 | WO2000070353A3 High throughput assay systems and methods |
| 04/26/2001 | WO2000070021A3 Differentiated human embryoid cells and a method for producing them |
| 04/26/2001 | WO2000067022A3 Laboratory examination of a body fluid or tissue sample |
| 04/26/2001 | WO2000066753A3 Modified vitamin k-dependent polypeptides |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000054581A3 Animal models and methods for sepsis |
| 04/26/2001 | WO2000046585A3 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose |
| 04/26/2001 | WO2000011219A9 Subtle mitochondrial mutations as tumor markers |
| 04/26/2001 | WO2000003244A3 Immortalized human keratinocyte cell line |
| 04/26/2001 | US20010000487 Preparing a tissue specimen for histology comprising fixing the tissue specimen, dehydrating, removing fat from specimen and imprgnating the specimen in a nonaquous solution for histology in two hours or less |
| 04/26/2001 | DE10031395A1 Device to test materials, e.g. trees and woods; has special cup-telescope boring device, with at least one motor for rotating and thrusting borer tool and display and recording unit |
| 04/26/2001 | DE10009479A1 Identification of candidate molecules with anticipated biological activity uses sets of differing molecules with applied descriptors |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388782A1 Method and system for assay and removal of harmful toxins during processing of tobacco products |